Page last updated: 2024-10-16

gamma-aminobutyric acid and Jactatio Capitis Nocturna

gamma-aminobutyric acid has been researched along with Jactatio Capitis Nocturna in 1 studies

gamma-Aminobutyric Acid: The most common inhibitory neurotransmitter in the central nervous system.
gamma-aminobutyric acid : A gamma-amino acid that is butanoic acid with the amino substituent located at C-4.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Park, SJ1
Yoon, KB1
Yoon, DM1
Kim, SH1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
[NCT02444351]50 participants (Actual)Interventional2015-06-26Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

1 trial available for gamma-aminobutyric acid and Jactatio Capitis Nocturna

ArticleYear
Botulinum Toxin Treatment for Nocturnal Calf Cramps in Patients With Lumbar Spinal Stenosis: A Randomized Clinical Trial.
    Archives of physical medicine and rehabilitation, 2017, Volume: 98, Issue:5

    Topics: Aged; Amines; Analgesics; Botulinum Toxins, Type A; Cyclohexanecarboxylic Acids; Female; Gabapentin;

2017